A contemporary approach to hypertrophic cardiomyopathy

Circulation. 2006 Jun 20;113(24):e858-62. doi: 10.1161/CIRCULATIONAHA.105.591982.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • AMP-Activated Protein Kinases
  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Amino Acid Substitution
  • Calcium Channel Blockers / therapeutic use
  • Cardiomyopathy, Hypertrophic, Familial / diagnosis
  • Cardiomyopathy, Hypertrophic, Familial / genetics*
  • Cardiomyopathy, Hypertrophic, Familial / pathology
  • Cardiomyopathy, Hypertrophic, Familial / therapy
  • Codon / genetics
  • Death, Sudden, Cardiac / etiology
  • Defibrillators, Implantable
  • Energy Metabolism / genetics
  • Female
  • Genes, Dominant
  • Genetic Heterogeneity
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Humans
  • Hypertrophy, Left Ventricular / epidemiology
  • Hypertrophy, Left Ventricular / etiology
  • Lysosomal Membrane Proteins / genetics
  • Lysosomal-Associated Membrane Protein 2
  • Male
  • Multienzyme Complexes / genetics
  • Muscle Proteins / deficiency
  • Muscle Proteins / genetics
  • Mutation, Missense
  • Pedigree
  • Phenotype
  • Protein Serine-Threonine Kinases / genetics
  • Sarcomeres / chemistry
  • Sarcomeres / pathology
  • Troponin T / genetics

Substances

  • Adrenergic beta-Antagonists
  • Calcium Channel Blockers
  • Codon
  • LAMP2 protein, human
  • Lysosomal-Associated Membrane Protein 2
  • Lysosomal Membrane Proteins
  • Multienzyme Complexes
  • Muscle Proteins
  • Troponin T
  • Protein Serine-Threonine Kinases
  • AMP-Activated Protein Kinases